Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 161 Squamous Cell Carcinoma of Head and Neck 95 Head and Neck Neoplasms 95 Colonic Neoplasms 46 Rectal Neoplasms 39 Neoplasm Metastasis 35 Carcinoma, Non-Small-Cell Lung 29 Carcinoma, Squamous Cell 25 Pancreatic Neoplasms 18 Neoplasms 18 Esophageal Neoplasms 18 Lung Neoplasms 17 Stomach Neoplasms 13 Laryngeal Neoplasms 12 Recurrence 11 Oropharyngeal Neoplasms 11 Mouth Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Colorectal Cancer Metastatic 10 Tongue Neoplasms 9 Carcinoma 9 Breast Neoplasms 9 Nasopharyngeal Carcinoma 8 Hypopharyngeal Neoplasms 8 Adenocarcinoma Of Esophagus 8 Laryngeal Diseases 6 Salivary Gland Neoplasms 5 Neoplasms, Squamous Cell 5 Glioblastoma 5 Uterine Cervical Neoplasms 4

Interventions

Metformin 2 Saline Solution 1 Lidocaine 1 Cetuximab 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Acne Vulgaris × Cetuximab × Clear all

NCT01382407 2017-04-27

Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab

Rambam Health Care Campus

Acne Vulgaris

Data powered by HemOnc (CC BY 4.0) Colophon ⚡